Myriamed - Less anmimal testing - better results !

Imagine a future where drug developers can bypass animal testing entirely—because the data they need comes directly from human biology in a dish.

Learn more about how the myriamed GmbH Platform reduces the need for animal testing !

At the heart of myriamed GmbH ’s innovation lies its suite of human-derived engineered tissue models, including products like myrCell and myrTissue. These platforms recreate both healthy and diseased heart and skeletal muscle environments, offering a highly physiological model that classic animal systems often fail to replicate .

1. Clinical Fidelity Through 3D Organoid Technology

myriamed GmbH ’s 3D organoid models mirror the structure and function of human tissues, providing researchers with superior predictive power for drug efficacy and safety—far beyond what traditional 2D cultures or animal models can offer .

2. Early Replacement of Animal Models

Aligned with the “Replace” principle of the 4Rs (Reduce, Refine, Replace, Regenerate), these entirely human platforms allow scientists to surpass non-human systems early in preclinical development—ushering in a patient-in-the-dish paradigm .

3. Quantitative Mode-of-Action Insights & Dosing Strategy

Thanks to their high functional maturity, the myriamed models enable mechanistic (mode-of-action) analyses and support rationale dosing strategies for early clinical trials—an area where animal models often fall short, especially when targeting human-specific pathways (e.g., proteins, RNAs) .

4. Streamlining Translation and Reducing Attrition

As a true drug development accelerator, myriamed’s platform helps researchers identify both desired and off‑target effects early on. This contributes to lower attrition rates and smoother transitions into human trials, all while aligning with ethical and economic standards .

5. Aligning with the 4Rs for Ethical Innovation

myriamed explicitly strives to Reduce costs and attrition, Refine targeting mechanisms, Replace animal-based systems, and Regenerate innovative therapeutics via phenotypic screening—all within ethical human-relevant contexts .

Final Thought: Scientific, Ethical, Efficient

By offering sophisticated human-mimetic tissue engineering, myriamed empowers researchers to conduct safer, more accurate preclinical testing—earlier and more ethically. This innovation not only minimizes reliance on animal models, but accelerates the path from discovery to clinical impact.